06 - 10 Oct 2024 HIV Research for Prevention Conference 2024 Congreso Distrito de Lima, Perú • Evento virtual 7 Seguidores GuardadoCompartir Interesado Solicitar un stand Registrarse Acerca de Expositores Oradores Reseñas Ofertas Interesado HIV Research fo... ...
IIDF:What research findings or topics at the conference are you most excited or looking forward to, and why do they hold significant importance for the HIV/AIDS field? Dr Lewin:The scientific presentations I am most excited about are around new prevention strategies - new ways to prevent HIV ...
WHO Collaborating Centre for Clinical Management, Training and Research on Emerging and Re-emerging Infectious Diseases Expert of World Health Organization Clinical Expert Group; Member of National Health and Health Commission Diseas...
本回答已于2024年8月30日进行了第10次更新，加入了U=U这一科学结论和中国目前的HIV流行病学和抗病毒...
The document is a collection of summaries of various research studies related to HIV prevention and treatment. The studies cover a range of topics, including the use of pre-exposure prophylaxis (PrEP), the development of HIV vaccines and antibodies, and the implementation of long-a...
Not only will STD-HIV AIDS-2024: Showcase the latest developments in HIV research, the conference will present brand-new data on COVID-19 and HIV, showcasing how HIV informs and intersects with the COVID-19 pandemic. From the latest advances in basic, clinical and prevention research to ...
J&J aims to change the course of the epidemic globally through innovative treatment and prevention solutions for people with HIV, and those at risk.
WHO Collaborating Centre for Clinical Management, Training and Research on Emerging and Re-emerging Infectious Diseases Expert of World Health Organization Clinical Expert Group; Member of National Health and Health Commission Disease Prevention and Control Expert Committee ...
Infectious Disease Frontier: What do you think are the important research directions of HIV long-acting preparations in the future? Dr. Charles Flexner: 开发具有更长给药间隔的制剂至关重要。目前,我们有lenacapavir,一种每六个月皮下注射的衣壳抑制剂。寻找lenacapavir的联合药物是一项具有挑战性的工作。
For more than 35 years, Gilead has been a leading innovator in the field of HIV, driving advances in treatment, prevention and cure research. Gilead researchers have developed 12 HIV medications, including the first single-tablet regimen...